미장지도미장지도US Stock Key LevelsSupport & Resistance
🏠HomeσSigma Map🗺️Tickers⭐Watchlist👤My Page
📊Market Dashboard🔥Today's Map🌐Global Briefing
📌Today's Issues🔬Research
🏛️Institutional Holdings🐜Korean Retail Flow
📚Study🎯Exit Helper📓Trade Journal📜Filings & Insiders🧰Tools🧭How to Read
미장지도미장지도미장지도US Stock Key LevelsSupport & Resistance
HomeSigma MapMarket DashboardTickersWatchlistToday's IssuesToday's MapInstitutional HoldingsMy PageResearchGlobal BriefingKorean Retail Flow
한글EN
LiveLive prices
로그인
🏠HomeσSigma Map🗺️Tickers⭐Watchlist👤My Page
NTRA logo

NTRA

Outside the watchlist

Natera, Inc.

333.69

-0.00% (최근 종가 333.69)

Loading chart...

Watchlist shortcuts

Edit

지수 (5)

  • SPY logoSPY
  • QQQ logoQQQ
  • VOO logoVOO
  • TQQQ logoTQQQ
  • QLD logoQLD

섹터 ETF (4)

  • SOXX logoSOXX
  • SOXL logoSOXL
  • IGV logoIGV
  • SMH logoSMH

빅테크 (6)

  • TSLA logoTSLA
  • META logoMETA
  • GOOGL logoGOOGL
  • AMZN logoAMZN
  • AAPL logoAAPL
  • MSFT logoMSFT

반도체 · 장비 (14)

  • NVDA logoNVDA
  • AVGO logoAVGO
  • MU logoMU
  • INTC logoINTC
  • TSM logoTSM
  • AMD logoAMD
  • MRVL logoMRVL
  • SNDK logoSNDK
  • SKHY logoSKHY
  • ASML logoASML
  • LRCX logoLRCX
  • AMAT logoAMAT
  • ARM logoARM
  • LITE logoLITE

AI 인프라 (6)

  • PLTR logoPLTR
  • ORCL logoORCL
  • NBIS logoNBIS
  • CRWV logoCRWV
  • VRT logoVRT
  • SMCI logoSMCI

디지털자산 (5)

  • COIN logoCOIN
  • CRCL logoCRCL
  • IREN logoIREN
  • MSTR logoMSTR
  • HOOD logoHOOD

에너지 · 소재 (7)

  • IONQ logoIONQ
  • MP logoMP
  • RGTI logoRGTI
  • SMR logoSMR
  • OKLO logoOKLO
  • BE logoBE
  • GEV logoGEV

우주 · 모빌리티 (3)

  • SPCX logoSPCX
  • RKLB logoRKLB
  • JOBY logoJOBY

Company Analysis

Sector
Healthcare
Industry
Diagnostics & Research
Headquarters
Austin, United States
Employees
6,135

Company profile — from Yahoo Finance

Natera, Inc., a diagnostics company, engages in the development and commercialization of molecular testing services worldwide. It offers Signatera, a personalized ctDNA blood test for MRD assessment, early recurrence monitoring, and evaluation of treatment response in patients previously diagnosed with cancer; Latitude, a blood-based MRD test for colorectal cancer; Altera, a tissue based comprehensive genomic profiling test; and Empower, a hereditary cancer screening test. The company also provides Panorama, a non-invasive prenatal test; Horizon, a carrier screening test; Fetal Focus, a single-gene NIPT, or sgNIPT, that screens for 21 single-gene inherited conditions; and Vistara, a single-gene NIPT, which screens for 25 single-gene conditions. In addition, it offers Anora, which tests and analyzes miscarriage tissue from women who have experienced one or more pregnancy losses; Empower, a hereditary cancer screening test; Prospera, a test to assess active rejection in patients who have undergone solid organ transplantation; Renasight, a kidney gene panel test; and Constellation software, a cloud-based distribution model. Further, the company provides NateraCore, a platform to support the patient and provider experience; phlebotomy services; and EMR integration services. The company serves independent laboratories, national and regional reference laboratories, medical centers and physician practices for its screening tests, research laboratories, and pharmaceutical companies through its direct sales force and laboratory distribution partners, as well as Constellation licensees under its cloud-based distribution model. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays for clinical and commercial use. The company has a collaboration with Diakonos Oncology Corp. to assess molecular response in patients with refractory melanoma. The company was formerly known as Gene Security Network, LLC and changed its name to Natera, Inc. in January 2012. Natera, Inc. was founded in 2003 and is headquartered in Austin, Texas.

Official site ↗Yahoo Finance ↗

Company information as provided by Yahoo Finance. Check the official filings before relying on it.

Size · Range · Profitability

Market Cap

481억 달러

PER

-

Trailing 12 months

Forward P/E

-3743.7배

Forward estimates

ROE

-12.5%

Return on equity

Dividend Yield

-

Beta

1.51

Volatility vs market

52주 최저 $157.43현재 $333.6952주 최고 $335.90

52주 범위에서 99% 지점입니다. 100%에 가까울수록 1년 최고가 부근입니다.

Source: Yahoo Finance

Wall Street Consensus

Average analyst price target

$336.74+0.9%

범위 $280.00 ~ $375.00 · 애널리스트 21명 · 종합의견 적극 매수 · 출처 Yahoo Finance

Analyst rating breakdown (2026-08-01)

Strong Buy 12Buy 14Hold 4Sell 0Strong Sell 0

월가는 이 종목을 뚜렷한 매수 우위로 보고 있습니다. (매수 26 · 관망 4 · 매도 0)

Annual Financials

Revenue trend

23억 달러

2022–2025 회계연도 · 축 단위는 달러입니다.

2022202320242025$2.3B

Net income trend

-2억 달러

2022–2025 회계연도 · 축 단위는 달러입니다.

2022202320242025$0M
YearRevenueOperating IncomeNet IncomeOperating Cash FlowNet Margin
202523억 달러-3억 달러-2억 달러2억 달러-9.0%
202417억 달러-2억 달러-2억 달러1억 달러-11.2%
202311억 달러-4억 달러-4억 달러-2억 달러-40.2%
20228억 달러-5억 달러-5억 달러-4억 달러-66.8%

회계연도 기준 실적입니다(달력 연도와 다를 수 있습니다). 출처: Yahoo Finance. 값이 없는 항목은 채우지 않고 "-"로 둡니다.

SEC Filings (latest 3)

  • 10-Q분기 실적보고서 — 숫자 자체보다 시장 예상치 대비 서프라이즈 여부가 중요합니다.↗

    2026-08-07

  • 8-K실적 발표 · 재무제표·증빙 첨부 — 실적 발표입니다. 숫자 자체보다 시장 예상치 대비 서프라이즈 여부가 중요합니다.↗

    2026-08-06

  • 8-K임원/이사 선임·사임 — 임원/이사 변경입니다. CEO·CFO급 교체라면 주가에 즉각 영향을 줄 수 있습니다.↗

    2026-07-06

Related News (latest 3)

  • Natera: The Growth May Not Justify Current Levels↗

    SeekingAlpha · 08. 26.

  • Tempus AI Just Had Their Entire Strategy Validated By Moderna's Vaccine Advance↗

    SeekingAlpha · 08. 20.

  • Natera: Even 30% Annual Growth Through 2030 Doesn't Support $310 Per Share↗

    SeekingAlpha · 08. 20.

What this ticker does not include

Prices, key stats, price targets, annual financials, filings and news above come straight from Yahoo Finance · Finnhub · SEC EDGAR, so they look the same for any US-listed ticker.

Support & resistance shows above whenever my TradingView indicator is sending alerts for the ticker. No alert is set up for this one yet, so there are no levels.
Option levels · MJM Score · REAL_BUY signals come through a Google Sheet and are still limited to the fixed watchlist. We leave them out rather than guess.